Overview

Fixed-Free HTN Trial

Status:
Unknown status

Trial end date:
2019-12-30

Target enrollment:

Participant gender:

Summary

Evaluation of the effect of FIXED triple anti-hypertensive therapy with losartan-amlodipin-HCTZ vs any free triple combination therapy chosen by the treating physician for patients with uncontrolled hypertension

Phase:

Phase 4

Details

Lead Sponsor:

Hotel Dieu de France Hospital

Treatments:

Amlodipine
Hydrochlorothiazide
Losartan